BackNuvectis Pharma Overview

Nuvectis Pharma Current Cash

Latest current cash for NVCT: $25M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$25.13M
↓ 15.85% YoYΔ $-4.73M vs prior year quarter

Peer average

Loading

Nuvectis Pharma Current Cash History

Loading

Nuvectis Pharma vs. peers: Current Cash Comparison

Loading

Nuvectis Pharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nuvectis Pharma (NVCT) FAQ

Nuvectis Pharma (NVCT) currently reports a current cash of $25M as of March 2026. That compares with $30M in the prior-year period — down 15.9% year over year. Use the charts on this page to explore Nuvectis Pharma's current cash history and peer comparisons.

Nuvectis Pharma's current cash decreased from $30M to $25M — a 15.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvectis Pharma reported $25M in current cash as of March 2026. That compares with $30M in the prior-year period — down 15.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvectis Pharma, and consider following NVCT for alerts when major investors trade the stock.